Professor Charlie C. Xue is Executive Dean, School of Health and Biomedical Sciences at RMIT University. He provides academic, research, professional, industry and community engagement leadership.
Distinguished Professor Charlie C. Xue commenced his current role as Executive Dean SHBS in January 2016. He has consulted staff extensively for the development of the Guiding Principles for School Operations (2016-2020), School Academic Structure (11 Disciplines under three Academic Clusters), identification of the School’s Teaching, Research and Business Development Priorities, finalisation of the School’s Mission and Vision, and development of the School’s Workplan (to 2020) with an annual School Operational Plan.
The School will achieve its objectives through teamwork and collaboration, delivery of quality student experience and research output and recognition of staff strengths and success. Previously at RMIT University, Prof Xue was Head of School, Health Sciences (2011-2015).
Outside the School, Professor Xue contributes to the strategic direction setting of the College of Science Engineering and Health as a member of the College Executive. Professor Xue works collaboratively with other members of the College Executive for the planning and development of academic programs, cross-disciplinary research and business development/commercial activities. He also contributes to the RMIT University’s Academic Board, Academic Promotion Review Panels and the Athena SWAN Committee to address the gender equality in the academic workforce.
Professor Xue also holds the following appointments:
- National Chair, Chinese Medicine Board of Australia, an appointment by the Australian Health Workforce Ministerial Council [from 2011-]
- Member, World Health Organization (WHO) Expert Advisory Panel for Traditional Medicine (appointed by Director-General of the WHO, Geneva [from 2007-]
- Director, WHO Collaborating Centre for Traditional Medicine, RMIT University [from 2005-]
Professor Xue's main research interests are evidence-based medicine and translational research with a focus on Complementary and Alternative Medicine (CAM, acupuncture and herbal medicine) for chronic respiratory diseases and pain management. His team consists of six postdoctoral fellows and a number of PhD candidates. He has established extensive research networks nationally and internationally. Professor Xue’s research has been supported by grants from the Australian National Health and Medical Research Council (NHMRC), Australian Research Council, Federal and State Government Grants, and international research collaboration grants.
Honours and awards
- Office of Learning and Teaching Citation (Team Leader), Australian Government, 2013
- RMIT Learning and Teaching Award (Team Leader), RMIT University, 2012
- Vice Chancellor Research Excellence Award, RMIT University, 2011
- Ralph McIntosh Medal, Council of RMIT University, May 2010
Research grant reviews and contribution to peer-reviewed journals
Professor Xue contributes to peer-review process for major grant funding schemes (including the NHMRC), journals as Advisory/Editorial Board Members and as a reviewer.
Industry and international consultancy
- Consultant/Chair/Advisor: for over 20 projects for the WHO [from 2002-]
- Honorary Advisor, Institute of Chinese Medicine, The Chinese University of Hong Kong, from August 2001-present
- Doctor of Philosophy, RMIT University, 2000, Australia
- Bachelor of Medicine, Guangzhou College of Chinese Medicine, 1987, China
- Yang, L.,Shergis, J.,Di, Y.,Zhang, T.,Lu, C.,Guo, X.,Fang, Z.,Xue, C.,Li, Y. (2020). Managing Depression with Bupleurum chinense Herbal Formula: A Systematic Review and Meta-Analysis of Randomized Controlled Trials In: The Journal of Alternative and Complementary Medicine, 26, 8 - 24
- Zheng, Z.,Layton, J.,Stelmach, W.,Crabbe, J.,Ma, J.,Briedis, J.,Atme, A.,Bourne, D.,Hau, R.,Cleary, S.,Xue, C. (2020). Using patient self-checklist to improve the documentation of risk of postoperative nausea and vomiting: an implementation project In: International Journal of Evidence-Based Healthcare, 18, 65 - 74
- Chen, Y.,Lin, L.,Wu, L.,Xu, Y.,Planche, J.,Zhang, T.,Wen, Z.,Worsnop, C.,Da Costa, C.,Thien, F.,Xue, C. (2020). Effect of panax ginseng (G115) capsules versus placebo on acute exacerbations in patients with moderate to very severe copd: A randomized controlled trial In: International Journal of COPD, 15, 671 - 680
- Qin, X.,Coyle, M.,Lu, Y.,Liang, J.,Wang, K.,Guo, X.,Zhang, A.,Mao, W.,Lu, C.,Xue, C.,Liu, X. (2020). Acupuncture for recurrent urinary tract infection in women: a systematic review and meta-analysis In: BJOG: An International Journal of Obstetrics and Gynaecology, , 1 - 10
- Xia, X.,May, B.,Zhang, A.,Guo, X.,Lu, C.,Xue, C.,Huang, Q. (2020). Chinese Herbal Medicines for Rheumatoid Arthritis: Text-Mining the Classical Literature for Potentially Effective Natural Products In: Evidence-based Complementary and Alternative Medicine, 2020, 1 - 14
- May, B.,Liu, Y.,Zhang, A.,Xue, C.,Lu, C.,Zhang, H.,Guo, X. (2020). Evidence-based Clinical Chinese Medicine Volume 17: Colorectal cancer, World Scientific, Singapore
- Zheng, Z.,Bai, L.,O�Loughlan, M.,Li, C.,Xue, C. (2019). Does Electroacupuncture Have Different Effects on Peripheral and Central Sensitization in Humans: A Randomized Controlled Study In: Frontiers in Integrative Neuroscience, 13, 1 - 11
- May, B.,Feng, M.,Parker, S.,Zhang, A.,Xue, C.,Zhao, Y.,You, J.,Liu, S.,Guo, X. (2019). Evidence-Based Clinical Chinese Medicine - Volume 9: Vascular Dementia, World Scientific, Singapore
- Zhang, S.,Liu, S.,Parker, S.,Zhang, A.,Xue, C.,Cai, Y.,Pan, R. (2019). Evidence-Based Clinical Chinese Medicine - Volume 12: Post Stroke Shoulder Complications, World Scientific, Singapore
- Di, Y.,Yang, L.,Shergis, J.,Zhang, A.,Xue, C.,Li, Y.,Lu, C.,Guo, X. (2019). Evidence-Based Clinical Chinese Medicine - Volume 14: Unipolar Depression, World Scientific , Singapore
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 9. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2019 to 2020)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 7. Funded by: Confucius Institute Headquarters Business Development Program Grant 2017 from (2017 to 2019)
- Culture aspects in the Development of evidence-based Chinese Medicine - Stage 6. Funded by: Confucius Institute Headquarters Business Development Program Grant 2016 from (2016 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 5. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2015 to 2018)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stage 4. Funded by: Confucius Institute Headquarters Business Development Program Grant pre-2014 from (2014 to 2014)
- Cultural Aspects in the Development of Evidence-Based Chinese Medicine - Stages 6. Funded by: Confucius Institute Headquarters Business Development Program Fund from (2016 -2017) - $220,000 [CIA]
- Evaluation of Traditional and Scientific Evidence of Chinese Medicine (Stage I, II and III projects), Guangdong Provincial Academy of Chinese Medical Sciences, 2008-2016, $3,050,000): [CIA]
- The China-Australia Research Centre for Chinese Medicine, 2013-2020, $2,400,000: CIA and Co-Director of the Centre
- Translational Medicine Projects at the China-Australia Research Centre for Chinese Medicine, 2016-2025, $8,229,113, CIA and Director of the Centre
35 PhD Completions and 9 Masters by Research Completions8 PhD Current Supervisions